![Jared Gollob](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Jared Gollob
Hoofd Techniek/Wetenschap/O&O bij
KYMERA THERAPEUTICS, INC.
Vermogen: 6 M $ op 31-05-2026
Profiel
Jared Gollob is Chief Medical Officer at Kymera Therapeutics, Inc. since 2018.
Formerly, Dr. Gollob was Director of the Biologic Therapy Program at Duke University from 2002 to 2007.
From 2012 to 2018, Dr. Gollob was Global VP of Medical Affairs & Clinical Development at Alnylam Pharmaceuticals, Inc. Education includes undergraduate and doctorate degrees from The Trustees of Columbia University in The City of New York.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 31-03-2026 | 71.359 ( 0,09% ) | 6 M $ | 31-05-2026 |
Actieve functies van Jared Gollob
| Bedrijven | Functie | Begin |
|---|---|---|
| KYMERA THERAPEUTICS, INC. | Hoofd Techniek/Wetenschap/O&O | 01-09-2018 |
Eerdere bekende functies van Jared Gollob
| Bedrijven | Functie | Einde |
|---|---|---|
| ALNYLAM PHARMACEUTICALS, INC. | Hoofd Techniek/Wetenschap/O&O | 01-08-2018 |
Duke University
 Duke University Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | 01-09-2007 |
Opleiding van Jared Gollob
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
88
Eerstegraads connecties
4
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 4 |
|---|---|
The Trustees of Columbia University in The City of New York
 The Trustees of Columbia University in The City of New York Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Duke University
Duke University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Alnylam Pharmaceuticals, Inc.
 Alnylam Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes therapeutics based on RNA interference | Health Technology |
Kymera Therapeutics, Inc.
 Kymera Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops immunology medicines for health problems | Health Technology |
